Application 021423
- Type
- NDA
- Sponsor
- PARKE DAVIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | NEURONTIN | GABAPENTIN | CAPSULE; ORAL | 800MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| GABAPENTIN | GABAPENTIN | Camber Pharmaceuticals, Inc. | b86c81d9-9a4a-4847-be18-520e5cc5dc4b | 2025-12-12 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | JVET PHARMACEUTICALS LLC | 63a5fc6d-ca57-4726-b70d-805ac023d959 | 2025-12-10 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Glenmark Pharmaceuticals Inc., USA | 3865a6e3-112c-490c-82ac-35401336b16e | 2025-12-05 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Precision Dose, Inc. | 021329d0-7d32-4fd8-81bf-a8b0d8b49e43 | 2025-12-04 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | Redpharm Drug | 44f2b497-55b2-864f-e063-6294a90ad6d5 | 2025-12-02 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Kesin Pharma Corporation | 4470a567-93a6-a293-e063-6394a90affc1 | 2025-11-25 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | b74a427c-9cc1-4b15-9ed2-cc891741fe67 | 2025-11-19 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Strides Pharma Science Limited | bec31452-b52b-4698-ba4c-0b614780ee84 | 2025-11-12 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Acella Pharmaceuticals, LLC | 3255245c-6ae6-46ab-a1c1-0b8d4d4cdaa2 | 2025-11-03 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 5134369d-c7f6-4569-a425-d50e5a5d694f | 2025-10-29 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Mullan Pharmaceutical Inc. | 47a22de2-ec66-45be-8648-89ed3ab6e67e | 2025-10-28 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 25befbfa-5125-4363-8306-f862e81c0a6f | 2025-10-28 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | d9d78138-e1e9-4107-9099-4910cb1422d8 | 2025-10-22 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 6e900fc4-a2b3-411f-9ab7-8dcbb97b697b | 2025-10-16 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | aa246838-609c-4254-a8ec-d6f463a17960 | 2025-10-16 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | efb86e22-5a84-4b33-aad0-71dd5a2c6c8f | 2025-10-13 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 1ead7343-ab25-41b5-af4f-f903470e1dd9 | 2025-10-10 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | A-S Medication Solutions | 781b0d62-a760-4371-8908-1f61329928a6 | 2025-10-10 | Warnings, Adverse reactions | GABAPENTIN |
| GABAPENTIN | GABAPENTIN | STALLION LABORATORIES PRIVATE LIMITED | b26fd0c6-6aab-4957-8a32-cc7adb9b5fc9 | 2025-10-03 | Warnings, Adverse reactions | GABAPENTIN |
| Gabapentin | GABAPENTIN | American Health Packaging | bbfdedd7-2baf-4bc6-be59-548a5cf21752 | 2025-10-03 | Warnings, Adverse reactions | GABAPENTIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.